Inkokeli yobuchwephesha bezonyango kwihlabathi jikelele uZimmer Biomet Holdings, Inc. ubhengeze ukugqitywa ngempumelelo utyando lokuqala lwehlabathi oluncediswa yirobhothi lokubuyisela igxalaba kusetyenziswa inkqubo yayo yamagxa eROSA. Utyando lwenziwa kwiKliniki yaseMayo nguDkt. John W. Sperling, uProfesa we-Orthopedic Surgery kwiKliniki yaseMayo eRochester, eMinnesota, kunye negalelo eliphambili kwiqela lophuhliso lwe-ROSA.
"I-start of ROSA Shoulder ibonisa isiganeko esimangalisayo kwi-Zimmer Biomet, kwaye sihloniphekile ngokuba necala lokuqala lesigulane lenziwa nguDkt. Sperling, owaziwayo ngokubanzi ngenxa yobuchule bakhe bokwakhiwa kwamagxa," kusho u-Ivan Tornos, uMongameli kunye neGosa eliLawulayo kwiZimmer Biomet. "Ihlombe le-ROSA liqinisa ukufuna kwethu ukuhambisa izisombululo ezintsha ezinceda oogqirha botyando ukuba benze iinkqubo ezinzima zamathambo."
"Ukongeza uncedo lotyando lwe-robotic kwi-shoulder replacement operation luyakwazi ukuguqula iziphumo ze-intra-operative kunye ne-post-operative ngelixa uphucula amava esigulane jikelele," kusho uDkt Sperling.
Igxalaba le-ROSA lifumene imvume ye-US FDA 510(k) ngoFebruwari ka-2024 kwaye yenzelwe zombini iindlela ze-anatomic kunye nokubuyisela umva kwegxalaba lokubuyisela umva, ivumela ukufakwa kofakelo oluchanekileyo. Ixhasa ukuthathwa kwezigqibo ezinolwazi olusekelwe kwi-anatomy eyodwa yesigulana.
Ngaphambi kokusebenza, iGxale le-ROSA lidibanisa kunye neSiginesha ONE 2.0 yeNkqubo yokuCwangciswa koCwangciso, isebenzisa indlela ye-3D esekelwe kumfanekiso wokujonga nokucwangcisa. Ngexesha lotyando, ibonelela ngedatha yexesha lokwenyani ukunceda ukwenza kunye nokuqinisekisa izicwangciso zomntu zokufakwa ngokuchanekileyo kokufakelwa. Inkqubo ijolise ekunciphiseni iingxaki, ukuphucula iziphumo zeklinikhi, kunye nokuphucula ukwaneliseka kwesigulane.
I-ROSA Shoulder iphucula izisombululo ze-ZBEdge Dynamic Intelligence, ibonelela ngetekhnoloji ephucukileyo kunye nepotifoliyo eyomeleleyo yeenkqubo zokufakelwa kwamagxa kumava omntu ngamnye.

Ixesha lokuposa: May-31-2024